Fair Value Calculator Fair Value Calculator
EN DE

KAMADGIRI (KAMADGIRI) Fair Value & Analysis

IN · Market cap ₹639M

K KAMADGIRI KAMADGIRI · BSE
Price₹108.90
Fair Value₹105.04
Upside-3.5%
Quality67/100
Watch KAMADGIRI for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹78.78 – ₹131.30

Fair value as of: Jul 5, 2026

From 22 valuation models · updated today

Share price −14.5% over the past month.

Price vs Fair Value (12 months)

₹135.84 ₹64.30 Fair Value ₹105.04 Jul 2025 Jul 2026

12‑month range ₹64.30 – ₹135.84 · fair‑value band ₹78.78 – ₹131.30 · the ₹108.90 price screens above the ₹105.04 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

KAMADGIRI (KAMADGIRI) currently trades at ₹108.90, while our model-based Fair Value estimate is ₹105.04 — implying the stock looks roughly 3.5% overvalued today. We read business quality at 67/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, KAMADGIRI generated revenue of ₹1.6B at a net margin of 2.0%. Revenue grew 4.7% year over year. It earns a return on equity of 8.2%. Net debt stands at ₹112M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹78.78 (bear case) to ₹131.30 (bull case); at ₹108.90, the current price sits within that range. The share trades about 25% below its 52-week high and 70% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.6B
Revenue growth (YoY) +4.7%
Net margin 2.0%
Return on equity 8.2%
Free cash flow ₹87.2M FY2025
P/E ratio 20.7
More key figures
Operating margin 2.7%
EPS (TTM) ₹5.25
EPS growth (YoY) -33.9%
Net debt ₹112M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

KAMADGIRI reported revenue of ₹1.6B in FY2025 versus ₹2.6B in FY2021, a compound −11.5%/yr. Reported net income was ₹30.8M in FY2025, compounding +74.9%/yr from FY2021.

Revenue −11.5%/yr
FY21 ₹2.6B
FY22 ₹2.8B
FY23 ₹2.2B
FY24 ₹1.8B
FY25 ₹1.6B
Net income +74.9%/yr
FY21 ₹3.3M
FY22 ₹14.8M
FY23 −₹14.1M
FY24 ₹12.0M
FY25 ₹30.8M

Is KAMADGIRI fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "KAMADGIRI Fair Value". https://www.fairvalue-calculator.com/stock/KAMADGIRI

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is KAMADGIRI (KAMADGIRI) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹105.04 versus a price of ₹108.90 — about −4% (overvalued). Model-based estimate, not financial advice.
What is the fair value of KAMADGIRI?
Our model-based fair value for KAMADGIRI is ₹105.04 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹108.90.
What is the quality score of KAMADGIRI?
KAMADGIRI has a Quality Score of 67/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of KAMADGIRI (KAMADGIRI)?
KAMADGIRI reported trailing-twelve-month revenue of about ₹1.6B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of KAMADGIRI?
The net profit margin of KAMADGIRI is about 2.0%, meaning it keeps roughly 2.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.